Geneos Wealth Management’s Orion OEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,800
Closed -$179K 2912
2021
Q4
$179K Sell
9,800
-1,200
-11% -$22.4K 0.01% 916
2021
Q3
$207K Sell
11,000
-4,000
-27% -$71.6K 0.01% 841
2021
Q2
$287K Hold
15,000
0.01% 707
2021
Q1
$297K Hold
15,000
0.01% 803
2020
Q4
$299K Hold
15,000
0.01% 684
2020
Q3
$180K Buy
15,000
+2,500
+20% +$30K 0.01% 717
2020
Q2
$121K Buy
12,500
+2,500
+25% +$23.1K 0.01% 832
2020
Q1
$74K Buy
10,000
+2,000
+25% +$28.9K 0.01% 955
2019
Q4
$154K Sell
8,000
-2,000
-20% -$36.1K 0.01% 798
2019
Q3
$166K Buy
10,000
+4,500
+82% +$73.6K 0.01% 716
2019
Q2
$117K Buy
5,500
+2,500
+83% +$49.4K 0.01% 848
2019
Q1
$56K Buy
+3,000
New +$75.3K ﹤0.01% 1088

Other funds holding OEC

Geneos Wealth Management's OEC Position: Q1 2022 in Review

Geneos Wealth Management sold out of Orion (OEC) in Q1 2022, closing a stake of 9,800 shares — an estimated $179K sold.

Geneos Wealth Management first reported a position in OEC in Q1 2019 and held it in 12 quarters. The position peaked at $299K in Q4 2020. 157 funds tracked by Wall St. Rank hold OEC as of Q1 2022.

  • Geneos Wealth Management reported no remaining Orion position as of Q1 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 9,800 Orion shares in Q1 2022, an estimated $179K.
  • Geneos Wealth Management first reported a position in Orion in Q1 2019 and held it in 12 quarters.
  • Geneos Wealth Management's Orion position peaked at $299K in Q4 2020.
  • 157 funds tracked by Wall St. Rank held Orion as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.